Cite
MLA Citation
A. Amiot et al.. “One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.” Alimentary pharmacology & therapeutics, vol. 46, no. 3, 2017, pp. 310–321. http://access.bl.uk/ark:/81055/vdc_100047426577.0x000039